Forty years ago, NIH started the DNA research. Next month, NIH is going to issue guidelines for the first groundbreaking gene-editing CRISPR-Cas9 medical treatment of myeloma, melanoma and sarcoma. This CRISPR-Cas9, though beneficial for disease treatment and prevention, may upend human evolution if some rogue institutions use it for eugenic alteration in embryo in the foreseeable future. https://www.washingtonpost.com/news/to-your-health/wp/2016/06/21/federal-panel-approves-first-test-of-crispr-editing-in-humans/
No comments:
Post a Comment